ClassyCoin

BitMinutes is the first prepaid airtime token to provide low-cost financial services to the world's two billion unbanked consumers. BitMinutes serve as the universal cryptocurrency for enabling global telecommunications providers, retail merchants and a network of trusted agents to offer free money transfer and guaranteed loans to six billion cellphone users. The primary goal of Bitminutes ICO is to provide access to key financial services for over two billion unbanked worldwide.

Review.Network is a project that aims to create a unique trusted high-intelligence user-company feedback platform based on blockchain and AI technologies. Review.Network provides direct communication between companies and customers, that helps carry on efficient top-tier market research feedback without any mediator. Our model also directly rewards participants for their valuable feedback. The platform's community can gain coins by producing content and working with quality reviews on the Review.Network platform. With the smart recommendation system implemented, it is easier for members to find the best goods and services with ease. The REW is the digital currency of the Review.Network platform. Companies purchase coins to conduct market research on the platform and reward users in exchange for the feedback they leave.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.

TrigID is the first and only Internet-based way to show that a real-world human is who they say they are. It enforces "one person, one identity" and you can verify that real-world identity with real-world identifiers like driver's license numbers, SSN's, addresses, phone numbers... All without giving anyone those identifiers.

Powered by blockchain technology, the little Phil platform is an entirely new way of giving that fixes trust issues with charities using a public ledger, smart contracts and unique digital identities (UDID) to provide givers with the Proof of Need and Proof of Impact required to re-establish trust in giving to charity. Little Phil uses blockchain technology and user experience (UX) designed around a positive psychology framework to allow people to have the oversight, control and emotional connection of a philanthropist, without giving large amounts. People are able to give on their terms through their smartphone and track their giving all the way to the moment it’s received. This will create an engaging experience that makes them genuinely feel the positive impact they have had on their cause. In addition to this, charities will have solutions to their fundraising and exploitation concerns at a much lower cost than they currently incur.

All Public Art (APA) provides a unique platform that contributes to the growth and sustainability of the global art community by supporting the art market, igniting artist-to-collector trading, and storing the provenance of art on the blockchain. With the AllPublicArt token and the creation of our API, we are deploying a new, convenient and effective way to trade art and track the history of artworks. All Public Art's implementation of blockchain technology will minimize counterfeit art, build trust within the art market, improve art trade services and increase economic and social benefits in the global art community. Thanks to blockchain technology, transparency is increased ensuring a more convenient and legitimate marketplace for trading art.